Latest SEC Filings

Postal Realty Trust, Inc.Postal Realty Trust Reports 21.4% Revenue Growth to $55.2 Million in Latest Filing

RIGEL PHARMACEUTICALS INCRigel Pharmaceuticals Reports Q2 2026 Financial Results with $78.7M Revenue

Belpointe PREP, LLCBelpointe PREP Reports Revenue Growth to $5.4 Million but Faces Increased Net Loss in Q2 2026

Ultra Clean Holdings, Inc.Ultra Clean Holdings Reports 24.3% Revenue Growth to $644.9 Million in Latest Quarter

Reservoir Media, Inc.Reservoir Media Reports 12% Revenue Growth to $41.5 Million, Net Loss Narrows

Xometry, Inc.Xometry Reports 41% Revenue Growth to $229.3 Million, Net Loss Improves

ALASKA AIR GROUP, INC.Alaska Air Group Reports $76 Million Net Loss in Q2 2026 Despite Revenue Growth

IDEAYA Biosciences, Inc.IDEAYA Biosciences Reports $8.9M Collaboration Revenue and $112.5M Net Loss in Q2 2026

CREDIT ACCEPTANCE CORPCredit Acceptance Corporation Reports 55.5% Increase in Net Income for Q2 2026

EverQuote, Inc.EverQuote Reports 24.6% Revenue Growth to $195.1 Million in Latest Quarter

OnKure Therapeutics, Inc.OnKure Therapeutics Reports Q2 2026 Financial Results with $15.3 Million Net Loss

RHYTHM PHARMACEUTICALS, INC.Rhythm Pharmaceuticals Reports 47% Revenue Growth to $71.3 Million in Q2 2026

Wayfair Inc.Wayfair Reports $3.519 Billion Revenue in Q2 2026, Despite $1 Million Net Loss

MORGAN STANLEYMorgan Stanley Reports 27% Revenue Growth to $21.3 Billion in Quarterly Results

TIGO ENERGY, INC.Tigo Energy Reports $25.4 Million Revenue in Q2 2026, Net Income Turnaround Achieved

TransDigm Group INCTransDigm Group Reports 22.5% Revenue Growth and Increased Net Income in Q3 Fiscal 2026

Sixth Street Specialty Lending, Inc.Sixth Street Specialty Lending Reports Decrease in Investment Income for Q2 2026

SSR MINING INC.SSR Mining Inc. Reports 9.5% Revenue Increase to $443.8 Million in Q2 2026

AGNT, Inc.AGNT, Inc. Reports 11% Revenue Growth to $1.45 Billion in Q2 2026

TPG Inc.TPG Inc. Reports $1.84 Billion in Quarterly Revenues, Significant Growth in Net Income

Syndax Pharmaceuticals IncSyndax Pharmaceuticals Reports 93% Revenue Growth to $72.8 Million in Q2 2026

Niagen Bioscience, Inc.Niagen Bioscience Reports Q2 2026 Financial Results with Decreased Revenue and Net Income

PACS Group, Inc.PACS Group Reports 9.1% Revenue Growth to $1.43 Billion in Latest Quarter

GLADSTONE CAPITAL CORPGladstone Capital Reports Q3 Financial Results with $13.3M Net Increase in Assets

Spyre Therapeutics, Inc.Spyre Therapeutics Reports $36.2 Million Net Loss and Increased Total Assets in Q2 2026